Google Scholar | Citations: 958 | h-index: 12 i10-index: 19
Irritable Bowel Syndrome: a literature review
Imagem licenciada por Canva.com
PDF (Portuguese (Brazil))

Keywords

Irritable bowel syndrome
Gastroenterology
Gastrointestinal microbiome

How to Cite

Irritable Bowel Syndrome: a literature review. (2022). Revista Eletrônica Acervo Médico, 18, e11009. https://doi.org/10.25248/reamed.e11009.2022

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To analyze the characteristics of Irritable Bowel Syndrome (IBS). Bibliographic Review: IBS is one of the most common disorders of gut-brain interactions (formerly called functional gastrointestinal disorders) and is estimated to affect about 1 in 10 people worldwide. Its clinical presentation is characterized by abdominal pain associated with a change in stool frequency or shape, in the absence of organic disease. Factors involved in pathogenesis include environmental and host factors such as food intolerance, antibiotics, enteric infections, altered pain perception and altered brain-gut interaction, dysbiosis, and psychosocial stressors. Final considerations: Irritable bowel syndrome (IBS) is a chronic and recurrent functional gastrointestinal disorder. The diagnosis of IBS, according to the Rome IV criteria, requires that patients have had recurrent abdominal pain (at least 1 day/week in the last 3 months) related to defecation, an associated change in stool frequency, and/or a associated in the form of feces. Its treatment is based on pharmacological measures that depend on the type of IBS, whether with diarrhea or not, in addition to dietary measures.

PDF (Portuguese (Brazil))

References

ADRIANI A, et al. Irritable bowel syndrome: the clinical approach. Panminerva Med, 2018; 60(4): 213-222.

ALTOBELLI E, et al. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients, 2017; 9(9): 940.

AZIZ MNM, et al. Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain. Nutrients, 2021; 13(9):3061.

BERUMEN A, et al. Post-infection Irritable Bowel Syndrome. Gastroenterol Clin North Am, 2021; 50(2):445-461.

BLACK CJ, FORD AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol, 2020; 17(8): 473-486.

BONETTO S, et al. Recent advances in the treatment of irritable bowel syndrome. Pol Arch Intern Med, 2021; 131(7-8): 709-715.

CAMILLERI M. Irritable Bowel Syndrome: Straightening the road from the Rome criteria. Neurogastroenterol Motil, 2020; 32(11): e13957.

CAMILLERI M. Management Options for Irritable Bowel Syndrome. Mayo Clin Proc, 2018; 93(12): 1858-1872.

EL-SALSHY M, et al. Dietary fiber in irritable bowel syndrome (Review). Int J Mol Med, 2017; 40(3):607-613.

FORD AC, et al. Irritable bowel syndrome. Lancet, 2020; 396(10263):1675-1688.

HERNDON CC, et al. Targeting the gut microbiota for the treatment of irritable bowel syndrome. Kaohsiung J Med Sci, 2020; 36(3): 160-170.

MISHIMA Y, ISHIHARA S. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome. Int J Mol Sci, 2020; 21(22):8664.

MOSER G, et al. Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wien Med Wochenschr, 2018; 168(3-4):62-66.

PIMENTEL M. Evidence-based management of irritable bowel syndrome with diarrhea. Am J Manag Care, 2018; 24(3):35-46.

RADOVANOVIC-DINIC B, et al. Irritable bowel syndrome - from etiopathogenesis to therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2018; 162(1): 1-9.

RODIÑO-JANEIRO BK, et al. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Adv Ther, 2018; 35(3):289-310.

SIMON E, et al. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome. Nutrients, 2021; 13(6):2112.

SUN JR, et al. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis. Saudi J Gastroenterol, 2020; 26(2): 66-77.

WIKINSON JM, GILL MC. Irritable Bowel Syndrome: Questions and Answers for Effective Care. Am Fam Physician, 2021; 103(12): 727-736.